TScan Therapeutics, Inc. (TCRX)
1.14
-0.06
(-5.00%)
USD |
NASDAQ |
Jan 15, 16:00
1.14
0.00 (0.00%)
Pre-Market: 08:08
TScan Therapeutics EPS Diluted (Quarterly): -0.275 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GT Biopharma, Inc. | -0.8268 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Geron Corp. | -0.0276 |
| Novavax, Inc. | -1.246 |
| XOMA Royalty Corp. | 0.6991 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.71M |
| Revenue (Quarterly) | 2.511M |
| Total Expenses (Quarterly) | 38.22M |
| Enterprise Value | -24.14M |
| Gross Profit Margin (Quarterly) | 69.45% |
| Profit Margin (Quarterly) | -1.42K% |
| Earnings Yield | -98.20% |
| Normalized Earnings Yield | -97.64 |